caffeine has been researched along with Chronic Hepatitis B in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the utility of the 13C-caffeine breath test in chronic hepatitis B virus and its ability to monitor response to lamivudine." | 7.73 | The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. ( Jones, DB; Katelaris, PH; Le Couteur, DG; Lin, BP; Ngu, MC; Park, GJ; Seow, F, 2005) |
| "The purpose of this study was to evaluate caffeine clearance, a quantitative measurement of metabolizing capacity of the liver, in chronic hepatitis B and C before and after interferon treatment." | 5.09 | Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy. ( Mahachai, V; Wittayalertpanya, S, 2001) |
| "To determine the utility of the 13C-caffeine breath test in chronic hepatitis B virus and its ability to monitor response to lamivudine." | 3.73 | The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. ( Jones, DB; Katelaris, PH; Le Couteur, DG; Lin, BP; Ngu, MC; Park, GJ; Seow, F, 2005) |
| "Obesity, non-alcoholic fatty liver and steatohepatitis as well as diabetes mellitus together also form a significant risk for HCC, due to the gradually increasing number of patients." | 2.46 | [Role of environmental factors in the etiology of hepatocellular carcinoma]. ( Tornai, I, 2010) |
| " Univariate and multivariate logistic regressions adjusting for age, gender, cigarette smoking, alcohol use, tea consumption and physical activity were conducted with dose-response analysis." | 1.37 | Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study. ( Chan, HL; Ho, SC; Leung, WW; Mok, TS; Wong, V; Yeo, W, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tornai, I | 1 |
| Leung, WW | 1 |
| Ho, SC | 1 |
| Chan, HL | 1 |
| Wong, V | 1 |
| Yeo, W | 1 |
| Mok, TS | 1 |
| Park, GJ | 1 |
| Katelaris, PH | 1 |
| Jones, DB | 1 |
| Seow, F | 1 |
| Lin, BP | 1 |
| Le Couteur, DG | 1 |
| Ngu, MC | 1 |
| Wittayalertpanya, S | 1 |
| Mahachai, V | 1 |
1 review available for caffeine and Chronic Hepatitis B
| Article | Year |
|---|---|
[Role of environmental factors in the etiology of hepatocellular carcinoma].
Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Caffeine; Carcinoma, Hepatocellular; Coffee; Contracepti | 2010 |
1 trial available for caffeine and Chronic Hepatitis B
| Article | Year |
|---|---|
Caffeine clearance in patients with chronic viral hepatitis: before and after interferon therapy.
Topics: Administration, Oral; Adult; Caffeine; Chromatography, High Pressure Liquid; Female; Hepatitis B, Ch | 2001 |
2 other studies available for caffeine and Chronic Hepatitis B
| Article | Year |
|---|---|
Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.
Topics: Adult; Caffeine; Carcinoma, Hepatocellular; Case-Control Studies; Coffee; Dose-Response Relationship | 2011 |
The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy.
Topics: Adult; Breath Tests; Caffeine; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Ma | 2005 |